MEGAN HORVATH: Open Payments
NPI 1295490498 · SUGARLOAF, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,217 in 123 payments from 13 companies in 2025. Trend: 2023 $2,301 · 2024 $1,881 · 2025 $2,217
Food & beverage: $2,208Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $665 |
| Janssen Biotech, Inc. | 17 | $344 |
| UCB, Inc. | 16 | $251 |
| Novartis Pharmaceuticals Corporation | 18 | $227 |
| Galderma Laboratories, L.P. | 10 | $191 |
| Lilly USA, LLC | 8 | $169 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $83 |
| LEO Pharma Inc. | 3 | $69 |
| GENZYME CORPORATION | 2 | $62 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
Products named: RINVOQ, TREMFYA, SKYRIZI, Bimzelx, COSENTYX, NEMLUVIO, TALTZ, DUPIXENT.
Industry payments across PA — which companies pay providers there.
